These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
140 related items for PubMed ID: 2979269
1. Treatment of steatorrhoea in cystic fibrosis: a comparison of enteric-coated microspheres of pancreatin versus non-enteric-coated pancreatin and adjuvant cimetidine. Stead RJ, Skypala I, Hodson ME. Aliment Pharmacol Ther; 1988 Dec; 2(6):471-82. PubMed ID: 2979269 [Abstract] [Full Text] [Related]
2. Enteric coated microspheres of pancreatin in the treatment of cystic fibrosis: comparison with a standard enteric coated preparation. Stead RJ, Skypala I, Hodson ME, Batten JC. Thorax; 1987 Jul; 42(7):533-7. PubMed ID: 3326213 [Abstract] [Full Text] [Related]
3. Effect of cimetidine on enzyme inactivation, bile acid precipitation, and lipid solubilisation in pancreatic steatorrhoea due to cystic fibrosis. Zentler-Munro PL, Fine DR, Batten JC, Northfield TC. Gut; 1985 Sep; 26(9):892-901. PubMed ID: 3849459 [Abstract] [Full Text] [Related]
4. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study. Vyas H, Matthew DJ, Milla PJ. Eur J Pediatr; 1990 Jan; 149(4):241-3. PubMed ID: 1689245 [Abstract] [Full Text] [Related]
5. Comparative study of varying regimens to improve steatorrhoea and creatorrhoea in cystic fibrosis: Effectiveness of an enteric-coated preparation with and without antacids and cimetidine. Gow R, Bradbear R, Francis P, Shepherd R. Lancet; 1981 Nov 14; 2(8255):1071-4. PubMed ID: 6118524 [No Abstract] [Full Text] [Related]
6. Efficacy of pancreatic enzyme supplementation in children with cystic fibrosis: comparison of two preparations by random crossover study and a retrospective study of the same patients at two different ages. Ansaldi-Balocco N, Santini B, Sarchi C. J Pediatr Gastroenterol Nutr; 1988 Nov 14; 7 Suppl 1():S40-5. PubMed ID: 3042938 [Abstract] [Full Text] [Related]
7. Effectiveness and safety of small vs. large doses of enteric coated pancreatic enzymes in reducing steatorrhea in children with cystic fibrosis: a prospective randomized study. Brady MS, Rickard K, Yu PL, Eigen H. Pediatr Pulmonol; 1991 Nov 14; 10(2):79-85. PubMed ID: 2030925 [Abstract] [Full Text] [Related]
8. The effect of cimetidine on maldigestion in cystic fibrosis. Cox KL, Isenberg JN, Osher AB, Dooley RR. J Pediatr; 1979 Mar 14; 94(3):488-92. PubMed ID: 423042 [Abstract] [Full Text] [Related]
9. Effectiveness of enteric coated pancreatic enzymes given before meals in reducing steatorrhea in children with cystic fibrosis. Brady MS, Rickard K, Yu PL, Eigen H. J Am Diet Assoc; 1992 Jul 14; 92(7):813-7. PubMed ID: 1624649 [Abstract] [Full Text] [Related]
10. Comparative trial of viokase, pancreatin and Pancrease pancrelipase (enteric coated beads) in the treatment of malabsorption in cystic fibrosis. Mitchell EA, Quested C, Marks RE, Pinnock RE, Elliott RB. Aust Paediatr J; 1982 Jun 14; 18(2):114-7. PubMed ID: 6923744 [No Abstract] [Full Text] [Related]
11. Pancreatic enzyme supplementation as acid-resistant microspheres versus enteric-coated granules in cystic fibrosis. A double placebo-controlled cross-over study. Petersen W, Heilmann C, Garne S. Acta Paediatr Scand; 1987 Jan 14; 76(1):66-9. PubMed ID: 3551493 [Abstract] [Full Text] [Related]
12. Comparative effects of antacids, cimetidine and enteric coating on the therapeutic response to oral enzymes in severe pancreatic insufficiency. Regan PT, Malagelada JR, DiMagno EP, Glanzman SL, Go VL. N Engl J Med; 1977 Oct 20; 297(16):854-8. PubMed ID: 20572 [Abstract] [Full Text] [Related]
13. Effectiveness of enteric-coated preparations on nutritional parameters in cystic fibrosis. A long-term study. Carroccio A, Pardo F, Montalto G, Japichino L, Iacono G, Collura M, Notarbartolo A. Digestion; 1988 Oct 20; 41(4):201-6. PubMed ID: 3243379 [Abstract] [Full Text] [Related]
14. Cimetidine as an adjunct to oral enzymes in the treatment of malabsorption due to cystic fibrosis. de Biéville F, Neijens HJ, Fernandes J, van Caillie M, Kerrebijn KF. Acta Paediatr Scand; 1981 Jan 20; 70(1):33-7. PubMed ID: 6908433 [Abstract] [Full Text] [Related]
15. Comparison of a high lipase pancreatic enzyme extract with a regular pancreatin preparation in adult cystic fibrosis patients. Gan KH, Heijerman HG, Geus WP, Bakker W, Lamers CB. Aliment Pharmacol Ther; 1994 Dec 20; 8(6):603-7. PubMed ID: 7696449 [Abstract] [Full Text] [Related]
16. Pancreatic enzyme replacement therapy for people with cystic fibrosis. Somaraju UR, Solis-Moya A. Cochrane Database Syst Rev; 2014 Oct 13; (10):CD008227. PubMed ID: 25310479 [Abstract] [Full Text] [Related]
17. Two enteric coated microspheres in cystic fibrosis. Williams J, MacDonald A, Weller PH, Fields J, Pandov H. Arch Dis Child; 1990 Jun 13; 65(6):594-7. PubMed ID: 2198848 [Abstract] [Full Text] [Related]
18. Therapy of pancreatogenic steatorrhoea: does acid protection of pancreatic enzymes offer any advantage? Lankisch PG, Lembcke B, Göke B, Creutzfeldt W. Z Gastroenterol; 1986 Dec 13; 24(12):753-7. PubMed ID: 3548109 [Abstract] [Full Text] [Related]
19. Placebo controlled trial of enteric coated pancreatin microsphere treatment in patients with unresectable cancer of the pancreatic head region. Bruno MJ, Haverkort EB, Tijssen GP, Tytgat GN, van Leeuwen DJ. Gut; 1998 Jan 13; 42(1):92-6. PubMed ID: 9505892 [Abstract] [Full Text] [Related]
20. Therapeutic potential and clinical efficacy of acid-resistant fungal lipase in the treatment of pancreatic steatorrhoea due to cystic fibrosis. Zentler-Munro PL, Assoufi BA, Balasubramanian K, Cornell S, Benoliel D, Northfield TC, Hodson ME. Pancreas; 1992 Jan 13; 7(3):311-9. PubMed ID: 1594552 [Abstract] [Full Text] [Related] Page: [Next] [New Search]